SEC Form D filing
CND Life Sciences, Inc., 2026-06-16
An SEC Form D private-offering notice from Scottsdale, AZ, a $6,316,514 filer-stated offering target in Biotech. Filed 2026-06-16. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
CND Life Sciences, Inc. Verified via SEC Form D
Filed 2026-06-16Filed to raise $6,316,514First money in 2026-06-09Raised so far $6,316,514HQ (as filed) Scottsdale, AZSector Biotech machine-classified from the filing aloneStage (inferred) EarlyCall status Debt-only offering
Source linked the Form D on EDGAR↗Named in the filing 6 executives & directors
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Health Cost IQ Inc., 2026-06-30, $1.5M, Chandler, AZ
- Qlaris Bio, Inc., 2026-06-17, $3.9M, Dedham, MA
- ACES Diagnostics, Inc., 2026-06-25, $3M, Paradise Valley, AZ
- Peptaris, Inc., 2026-06-16, $4M, Philadelphia, PA
- Siensmetrica, Inc., 2026-06-18, $4M, Tucson, AZ
- Memento Medicines, Inc., 2026-06-16, $93M, Boston, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.